Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Dr Reddy's Laboratories (NYSE:RDY) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Dr Reddy's Laboratories (RDY) operate in?

Dr Reddy's Laboratories is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Dr Reddy's Laboratories Stock (NYSE: RDY) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	10.00 / 1.84M
Day Range	- - -
52 Wk Range	13.02 - 16.89
Market Cap	$10.88B
P/E Ratio	17.66
Dividend Yield	0.73%
Exchange	NYSE
RSI	26
Short Interest	2.61%
Days to Cover	7.65

Recent News

Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business

Dr. Reddy's Q3 FY2025 revenue reached $977 million, up 16%, with $165M net income. Growth fueled by NRT portfolio and global generics expansion.

Vandana Singh

CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices

CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and injunctions.

Vandana Singh

Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?

The top-performing stocks last week were TEVA, KVYO, DRI, DOCS, BIRK, JBL, NBIX, GME, RDY, and LI. Did you have any of them in your portfolio?

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	10.00 / 1.84M
Day Range	- - -
52 Wk Range	13.02 - 16.89
Market Cap	$10.88B
P/E Ratio	17.66
Dividend Yield	0.73%
Exchange	NYSE
RSI	26
Short Interest	2.61%
Days to Cover	7.65

About Dr. Reddy`s Laboratories Ltd.

Sector

Health Care

Industry

Pharmaceuticals

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant pres...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Dr Reddy's Laboratories (RDY) stock?

You can purchase shares of Dr Reddy's Laboratories (NYSE:RDY) through any online brokerage.

View our list of the best stock brokerages

Who are Dr Reddy's Laboratories (RDY) competitors?

Other companies in Dr Reddy's Laboratories’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).

What is the forecast, or price target, for Dr Reddy's Laboratories (RDY) stock?

Dr Reddy's Laboratories has a consensus price target of $17.00.

What is the current price for Dr Reddy's Laboratories (RDY)?

The stock price for Dr Reddy's Laboratories (NYSE: RDY) is $13.06 last updated February 25, 2025 at 9:13 AM EST.

Does Dr Reddy's Laboratories (RDY) pay a dividend?

A quarterly cash dividend of 0.48 per share of Class A Common Stock. The quarterly cash dividend was payable on August 12, 2024 to stockholders of record on July 15, 2024.

When is Dr Reddy's Laboratories (NYSE:RDY) reporting earnings?

Dr Reddy's Laboratories’s Q4 earnings are confirmed for Tuesday, May 6, 2025.

Is Dr Reddy's Laboratories (RDY) going to split?

There is no upcoming split for Dr Reddy's Laboratories.

What sector and industry does Dr Reddy's Laboratories (RDY) operate in?

Dr Reddy's Laboratories is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Comments

Dr Reddy's Laboratories

Dr Reddy's Laboratories (RDY) Forecast